
|Videos|March 9, 2015
Improving the Relationship Between Manufacturers and Specialty Pharmacies
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.
Advertisement
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Recognizing Immunizing Pharmacists in the Community
2
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
3
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
4
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
5

















































































































































































































